HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells.

Abstract
An interleukin (IL)-4-containing tumor environment is reported to be beneficial for immune clearance of tumor cells in vivo; however, the effect of IL-4 on the effector CD8+ T cells contributing to tumor clearance is not well defined. We have used the immunogenic HLA-CW3-expressing P815 (P.CW3) mastocytoma and investigated whether IL-4 expression by the tumor affects tumor clearance and, if so, whether it alters the tumor-induced Vbeta10+ CD8+ T-cell response. P.CW3 were stably transfected with IL-4 or the empty control vector, and independent cell lines were injected i.p. into syngeneic DBA/2 mice. After apparent clearance of primary tumors over 12 to 15 days, secondary tumors arose that lacked surface expression and H-2-restricted antigen presentation of CW3 in part due to the loss of the HLA-CW3 expression cassette. Surprisingly, mice that received IL-4-producing tumor cells showed delayed primary tumor clearance and were significantly more prone to develop secondary tumors compared with mice receiving control tumor cells. Tumor clearance was dependent on CD8+ T cells. The IL-4-secreting P.CW3 tumor cells led to markedly higher mRNA expression of IL-4 and granzyme A and B but no differences in IFN-gamma and IL-2 production, cell proliferation, or ex vivo CTL activity in primary Vbeta10+ CD8+ T cells when compared with the control tumor cells. We concluded that tumor-derived IL-4 selectively changed the quality of the tumor-induced CD8+ T-cell response and resulted in unexpected negative effects on tumor clearance. These data bring into question the delivery of IL-4 to the tumor environment for improving tumor immunotherapy.
AuthorsStuart Olver, Penny Groves, Kathy Buttigieg, Edward S Morris, Michelle L Janas, Anne Kelso, Norbert Kienzle
JournalCancer research (Cancer Res) Vol. 66 Issue 1 Pg. 571-80 (Jan 01 2006) ISSN: 0008-5472 [Print] United States
PMID16397274 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-C Antigens
  • HLA-C*03 antigen
  • Interleukin-4
Topics
  • Animals
  • CD8-Positive T-Lymphocytes (immunology)
  • Cell Line, Tumor
  • Female
  • Gene Expression
  • HLA-C Antigens (immunology)
  • Interleukin-4 (biosynthesis, genetics, immunology)
  • Mastocytoma (genetics, immunology)
  • Mice
  • Mice, Inbred DBA
  • T-Lymphocytes, Cytotoxic (immunology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: